Prepregnancy and Gestational Diabetes and Cessation of Breastfeeding <1 Week Postpartum,United States,2016-2018

Abstract

Objectives:

Diabetes may delay milk letdown, and perceiving milk production as insufficient can lead to breastfeeding cessation. We evaluated whether prepregnancy or gestational diabetes is associated with cessation of breastfeeding by 1 week postpartum.

Methods:

We analyzed 2016-2018 data from 42 sites in the Pregnancy Risk Assessment Monitoring System, a population-based survey of women with a recent live birth. Participants were surveyed 2-6 months after childbirth. We used logistic regression models to evaluate the relationship between prepregnancy or gestational diabetes only and breastfeeding <1 week postpartum among women who had initiated breastfeeding.

Results:

Among 82 050 women who initiated breastfeeding, 4.5% reported breastfeeding <1 week postpartum. Overall, 11.7% of women reported any history of diabetes in the 3 months before becoming pregnant; 3.3% reported prepregnancy diabetes, and 8.4% reported gestational diabetes only. In both unadjusted and adjusted models, the prevalence of breastfeeding <1 week postpartum did not differ significantly among women with prepregnancy diabetes or gestational diabetes only compared with women without any history of diabetes. The prevalence of breastfeeding <1 week postpartum was 4.4% among women without any history of diabetes, 5.6% among women with prepregnancy diabetes (adjusted prevalence ratio [aPR] = 1.15; 95% CI, 0.91-1.46), and 4.5% among women with gestational diabetes only (aPR = 1.01; 95% CI, 0.84-1.20).

Conclusions:

We found no association between a history of diabetes prepregnancy or gestational diabetes only and breastfeeding <1 week postpartum in a large, population-based survey of postpartum women who initiated breastfeeding. Regardless of their diabetes status, women who want to breastfeed might benefit from interventions that support their ability to continue breastfeeding.

Keywords

breastfeeding diabetes mellitus pregnancy survey United States PRAMS

Breastfeeding is associated with considerable health benefits for both mother and child. Mothers who breastfeed have a lower risk, compared with mothers who do not breastfeed, of type 2 diabetes, postpartum depression, breast cancer, and ovarian cancer.^1,2 Breastfed children have lower rates than nonbreastfed children of infant mortality, respiratory illness, and asthma.^1,3-5 Furthermore, formula use incurs health care costs: the direct medical costs of suboptimal breastfeeding was estimated at $3 billion in 2014 in the United States.⁶ Consequently, the American Academy of Pediatrics recommends exclusively breastfeeding for about the first 6 months of infant life, followed by breastfeeding in combination with complementary foods until at least 12 months of age.⁷ However, only 25% of infants born in 2017 in the United States were exclusively breastfed through 6 months, and only 35% of infants were breastfed for 1 year.⁸

Successful long-term breastfeeding for mothers with prepregnancy or gestational diabetes is particularly important because metabolic adaptations during lactation can reverse atherogenic and diabetogenic effects from pregnancy.⁹ Diabetes, however, is associated with decreased breastfeeding at 2 months postpartum.¹⁰ It is unknown whether, among the subset of women who initiate breastfeeding, women with diabetes are at higher risk, compared with women without diabetes, of discontinuing breastfeeding before they intend to. Some evidence suggests that diabetes may inhibit lactogenesis stage II, defined as the initial onset of copious production of milk within the first 72 hours postpartum.^11-16 Because delays in milk letdown or perceiving milk production as insufficient are key causes of discontinuation in the immediate postpartum period,^17,18 diabetes theoretically could lead to breastfeeding cessation in this early period. Thus, our objective was to evaluate the associations between diabetes type (prepregnancy or gestational, assessed separately) and cessation of breastfeeding in the first week postpartum among women who initiated breastfeeding.

Methods

Overview of Survey

We used data from the Centers for Disease Control and Prevention (CDC) Pregnancy Risk Assessment Monitoring System (PRAMS), a surveillance system conducted by CDC in collaboration with state and jurisdiction health departments, which has been described elsewhere.¹⁹ Using both mail and telephone data collection methods, PRAMS collects site-specific, population-based, self-reported data on maternal behaviors and experiences before, during, and shortly after pregnancy among women who had a live birth. Women are randomly sampled from site birth certificates at 2-6 months postpartum and are invited to complete the survey by mail. We used 2016-2018 data from sites that achieved a 55% response rate threshold for data release for at least 1 study year. The institutional review boards (IRBs) of CDC and PRAMS sites provided ethical and approval review for the PRAMS protocol. The Ohio State University IRB determined our analysis to be exempt from review because of its use of only deidentified, publicly available data.

Measure of Diabetes

We created an independent variable for having prepregnancy diabetes, gestational diabetes only (ie, no prepregnancy diabetes), or neither based on the following 2 yes/no questions: (1) “During the 3 months before you got pregnant with your new baby, did you have type 1 or type 2 diabetes (NOT gestational diabetes or diabetes that starts during pregnancy)?” and (2) “During your most recent pregnancy, did you have gestational diabetes (diabetes that started during this pregnancy)?” We classified women who responded that they had both prepregnancy diabetes and gestational diabetes as having prepregnancy diabetes. We defined “without diabetes” as not having any history of diabetes.

Measure of Breastfeeding Cessation at <1 Week Postpartum

Participants were asked, “Did you ever breastfeed or pump breast milk to feed your new baby, even for a short period of time?” Those who responded yes were asked whether they currently were breastfeeding or feeding their baby pumped milk (yes or no). Those who were no longer breastfeeding when they completed the PRAMS survey were asked to report the duration, in weeks or months, that they breastfed. For our primary outcome, breastfeeding <1 week postpartum, we created a dichotomous variable (yes or no) for breastfeeding for <1 week among those who initiated any breastfeeding (ie, including feeding at the breast or pumping milk). At the time of survey completion, women who reported their infants were deceased or not living with them were instructed to skip questions on breastfeeding.

Confounders

We considered the following characteristics as confounders given their association in the literature with diabetes and breastfeeding <1 week postpartum^20-29: marital status (married or unmarried), maternal education (<high school diploma, high school diploma or GED [General Educational Development], or ≥some college), race and ethnicity (non-Hispanic Black, non-Hispanic White, Hispanic, non-Hispanic American Indian/Alaska Native, non-Hispanic Other [reported ≥1 race or other non-White], or non-Hispanic Asian or Pacific Islander), age (<20, 20-24, 25-34, and ≥35 y), chronic hypertension (yes or no), enrollment in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) during pregnancy (yes or no), any cigarette use during pregnancy (yes or no), delivery method (cesarean section or vaginal delivery), infant birth weight (<2500 g [low birth weight], 2500-4000 g [normal birth weight], >4000 g [macrosomia]), and body mass index (BMI; in kg/m²; underweight [<18.5], overweight [25.0-29.9], obese [≥30.0], and normal [18.5-24.9]). Most confounders included in the PRAMS dataset were derived from birth certificate data; however, BMI was a composite variable in the PRAMS dataset that was computed from self-reported weight and height in the PRAMS survey.

Statistical Analysis

Among women who initiated breastfeeding, we examined the weighted prevalence of breastfeeding <1 week postpartum and confounders of interest by diabetes status. We excluded from analysis women who did not initiate breastfeeding, because the objective of this analysis was to assess breastfeeding cessation among those who had initiated breastfeeding. While other factors independent of physiologic factors (eg, breastfeeding intention) may influence breastfeeding initiation, we were unable to control for these other factors with the data available in the PRAMS dataset.

We used 95% CIs to assess differences in the distribution of characteristics by diabetes status; that is, we used nonoverlapping CIs to indicate significant differences. We computed unadjusted prevalence ratios (PRs) using unadjusted logistic regression models to evaluate the relationship between each confounder, prepregnancy diabetes, and gestational diabetes only and breastfeeding <1 week postpartum. We constructed a separate model for each confounder. We then constructed the final adjusted logistic regression model to compute adjusted PRs (aPRs) that accounted for the confounders. We also conducted sensitivity analyses to assess (1) differences between women included in the analysis and women excluded because of missing data on covariates, (2) whether the inclusion of women with missing data on covariates affected the regression results, and (3) differences in breastfeeding duration at ≤2 (vs >2) and ≤4 (vs >4) weeks postpartum. To make the data representative of each site’s population of live births, we used sample weights to account for the sampling design, nonresponse, and noncoverage. We conducted the analyses using SAS-callable SUDAAN version 11.0.3 (RTI International).

Results

Overall, data from surveys conducted in 2016 (31 sites), 2017 (36 sites), and 2018 (31 sites) were eligible for inclusion (Figure). The weighted mean response rate for these 42 sites was 61% during the study period. Our analytic sample excluded women who reported their infants were deceased or not living with them at the time of survey completion (n = 1942) and women who did not initiate breastfeeding (n = 12 707). After excluding women with missing data on breastfeeding duration (n = 2612), diabetes status (n = 1422), and confounders (n = 7377), our final analytic sample included 82 050 women. A higher proportion of women with missing data than women in the analytic sample were unmarried; had ≤high school education; were non-Hispanic Black, non-Hispanic Asian or Pacific Islander, or Hispanic; were aged ≤24 years; were enrolled in WIC during pregnancy; and had an infant with a low birth weight. The distribution of other characteristics was similar between women included in the analytic sample and women excluded because of missing data (online-only Supplemental Table S1).

Figure.

Selection and exclusion of respondents for analyses of data from the Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2018, to compare breastfeeding <1 week postpartum among women with and without diabetes. Data source: Shulman et al.¹⁹

Most women in the analytic sample were married, had completed at least some college, were non-Hispanic White, and were aged ≥25 years (Table 1). Most women did not have chronic hypertension, were not enrolled in WIC during pregnancy, and did not report cigarette use during pregnancy. Nearly half had a normal prepregnancy BMI. Most women had a vaginal delivery (70.1%) and gave birth to an infant with a normal birth weight (84.8%). While 88.3% of women (n = 71 751) did not have diabetes during their pregnancy, 3.3% had prepregnancy diabetes and 8.4% had gestational diabetes only. Overall, 4.5% of women had ceased breastfeeding by 1 week postpartum.

Table 1.

Characteristics of postpartum women who initiated breastfeeding, overall and by diabetes status, Pregnancy Risk Assessment Monitoring System, 2016-2018^a

Characteristic	Overall, unweighted no. (weighted %; N = 82 050)	Diabetes
		Prepregnancy^b (n = 2869)		Gestational only (n = 7430)		Neither (n = 71 751)
		No.	% (95% CI)	No.	% (95% CI)	No.	% (95% CI)
Marital status
Married	52 550 (66.8)	1842	67.6 (64.8-70.3)	5084	71.0 (69.3-72.6)	45 624	66.4 (65.9-66.9)
Unmarried	29 500 (33.2)	1027	32.4 (29.7-35.2)	2346	29.0 (27.4-30.7)	26 127	33.6 (33.1-34.1)
Education completed
<High school	7933 (9.2)	321	9.3 (7.7-11.0)	755	9.2 (8.2-10.3)	6857	9.2 (8.8-9.5)
High school diploma or GED	18 028 (21.9)	671	23.7 (21.3-26.4)	1584	20.6 (21.4-22.4)	15 773	21.9 (21.4-22.4)
≥Some college	56 089 (68.9)	1877	67.0 (64.2-69.7)	5091	70.2 (68.5-71.9)	49 121	68.9 (68.4-69.4)
Race and ethnicity
Non-Hispanic White	41 470 (59.8)	1356	57.7 (54.8-60.6)	3170	52.0 (50.2-53.8)	36 944	60.6 (60.1-61.1)
Non-Hispanic Black	12 715 (12.3)	505	11.8 (10.1-13.6)	1038	11.1 (10.0-12.3)	11 172	12.5 (12.1-12.8)
Hispanic	15 071 (18.0)	516	18.5 (16.2-21.1)	1496	20.5 (19.0-22.1)	13 059	17.8 (17.3-18.2)
Non-Hispanic American Indian/Alaska Native	3020 (0.7)	121	1.0 (0.7-1.3)	358	1.0 (0.9-1.2)	2541	0.7 (0.7-0.7)
Non-Hispanic Asian or Pacific Islander	5604 (6.0)	223	8.0 (6.5-9.8)	931	11.9 (10.7-13.1)	4450	5.4 (5.2-5.6)
Non-Hispanic Other^c	4170 (3.1)	148	3.0 (2.3-4.0)	437	3.4 (2.9-4.1)	3585	3.1 (2.9-3.3)
Age, y
<20	3588 (4.0)	86	2.8 (2.0-3.9)	120	1.0 (0.8-1.4)	3382	4.3 (4.0-4.5)
20-24	14 618 (17.4)	363	12.8 (10.9-15.1)	794	9.6 (8.6-10.7)	13 461	18.3 (17.9-18.8)
25-34	48 883 (60.2)	1694	61.0 (58.2-63.8)	4399	60.9 (59.1-62.6)	42 790	60.1 (59.5-60.6)
≥35	14 961 (18.5)	726	23.3 (21.0-25.8)	2117	28.5 (26.9-30.1)	12 118	17.3 (16.9-17.8)
Chronic hypertension
Yes	8801 (8.3)	540	14.6 (12.7-16.7)	1362	14.9 (13.7-16.2)	6899	7.5 (7.2-7.8)
No	73 249 (91.7)	2329	85.4 (83.3-87.3)	6068	85.1 (83.8-86.3)	64 852	92.5 (92.2-92.8)
Enrolled in WIC during pregnancy
Yes	29 192 (32.0)	1138	35.8 (33.0-38.6)	2735	32.9 (31.3-34.7)	25 319	31.8 (31.2-32.3)
No	52 858 (68.0)	1731	64.2 (61.4-67.0)	4695	67.1 (65.3-68.7)	46 432	68.2 (67.7-68.8)
Prepregnancy body mass index, kg/m²
Underweight (<18.5)	2893 (3.4)	58	1.4 (1.0-2.0)	142	1.8 (1.4-2.4)	2693	3.6 (3.4-3.8)
Normal (18.5-24.9)	37 710 (47.2)	1033	38.5 (35.7-41.3)	2158	30.3 (28.6-32.0)	34 519	49.1 (48.6-49.7)
Overweight (25.0-29.9)	20 850 (25.8)	701	26.1 (23.6-28.7)	1981	27.3 (25.8-29.0)	18 168	25.7 (25.2-26.2)
Obese (≥30.0)	20 597 (23.6)	1077	34.1 (31.4-37.0)	3149	40.5 (38.8-42.3)	16 371	21.7 (21.2-22.1)
Cigarette use during pregnancy
Yes	5635 (5.6)	219	7.5 (6.0-9.3)	534	5.7 (5.0-6.6)	4882	5.5 (5.2-5.7)
No	76 415 (94.4)	2650	92.5 (90.7-94.0)	6896	94.3 (93.4-95.0)	66 869	94.5 (94.3-94.8)
Delivery method
Cesarean section	26 545 (29.9)	1312	42.3 (39.4-45.2)	3089	38.2 (36.5-40.0)	22 144	28.6 (28.1-29.1)
Vaginal delivery	55 505 (70.1)	1557	57.7 (54.8-60.6)	4341	61.8 (60.0-63.5)	49 607	71.4 (70.9-71.9)
Infant birthweight, g
<2500	16 399 (6.6)	707	8.9 (7.8-10.0)	1671	8.2 (7.6-8.9)	14 021	6.4 (6.2-6.6)
2500-4000	59 750 (84.8)	1864	79.0 (76.9-81.1)	5147	81.9 (80.6-83.1)	52 739	85.3 (85.0-85.7)
>4000	5901 (8.5)	298	12.1 (10.4-14.1)	612	9.9 (8.9-11.0)	4991	8.3 (8.0-8.6)
Breastfeeding cessation
<1 week postpartum	3615 (4.5)	172	5.6 (4.5-7.1)	329	4.5 (3.8-5.4)	3114	4.4 (4.2-4.7)
≥1 week postpartum or still breastfeeding	78 435 (95.5)	2697	94.4 (92.9-95.5)	7101	95.5 (94.6-96.2)	68 637	95.6 (95.3-95.8)

Abbreviations: GED, General Educational Development; WIC, Special Supplemental Nutrition Program for Women, Infants, and Children.

Data source: Shulman et al.¹⁹ Percentages may not add to 100 because of rounding.

Type 1 or type 2.

Includes women who self-reported ≥1 race or other non-White on the birth certificate.

The distribution of selected characteristics differed between women with and without diabetes in the 3 months before becoming pregnant. Compared with women without diabetes, a higher proportion of women with either prepregnancy or gestational diabetes were non-Hispanic Asian or Pacific Islander, were aged ≥35 years, had hypertension, had obesity prepregnancy, had a cesarean section, and had an infant with a low birth weight.

In adjusted analyses, the prevalence of breastfeeding <1 week postpartum was significantly higher among women who had the following demographic characteristics: were unmarried (vs married), had ≤high school diploma or GED (vs ≥some college), were non-Hispanic Black or non-Hispanic White (vs non-Hispanic Asian or Pacific Islander), and were aged <20 years (vs aged ≥35 y). The prevalence of breastfeeding <1 week postpartum was also significantly higher among women reporting the following conditions or behaviors: having chronic hypertension (vs not), enrollment in WIC during pregnancy (vs not), an overweight or obese prepregnancy BMI (vs normal prepregnancy BMI), smoked cigarettes during pregnancy (vs not), and delivered via cesarean section (vs vaginal delivery; Table 2). The prevalence of breastfeeding <1 week postpartum was lower among women with infants who had a low birth weight (vs normal birthweight; aPR = 0.82; 95% CI, 0.72-0.94).

Table 2.

Unadjusted and adjusted prevalence ratios for cessation of breastfeeding at <1 week postpartum among postpartum women who initiated breastfeeding, Pregnancy Risk Assessment Monitoring System, 2016-2018^a

Characteristic	Total unweighted no. (N = 82 050)	Breastfeeding <1 week postpartum
Characteristic	Total unweighted no. (N = 82 050)	Unweighted no. (weighted %) (n = 3615)	Prevalence ratio (95% CI)	Adjusted prevalence ratio^b (95% CI)
Diabetes
Prepregnancy (type 1 or type 2)	2869	172 (5.6)	1.27 (1.00-1.60)	1.15 (0.91-1.46)
Gestational only	7430	329 (4.5)	1.02 (0.86-1.22)	1.01 (0.84-1.20)
None	71 751	3114 (4.4)	1 [Reference]	1 [Reference]
Marital status
Married	52 550	1497 (3.1)	1 [Reference]	1 [Reference]
Unmarried	29 500	2118 (7.2)	2.32 (2.10-2.57)	1.48 (1.31-1.68)
Education completed
<High school	7933	619 (8.3)	2.66 (2.30-3.07)	1.89 (1.61-2.22)
High school diploma or GED	18 028	1252 (7.2)	2.30 (2.06-2.58)	1.65 (1.45-1.86)
≥Some college	56 089	1744 (3.1)	1 [Reference]	1 [Reference]
Race and ethnicity
Non-Hispanic White	41 470	1585 (4.1)	1.71 (1.35-2.17)	1.36 (1.07-1.72)
Non-Hispanic Black	12 715	889 (6.8)	2.83 (2.19-3.65)	1.51 (1.16-1.96)
Hispanic	15 071	645 (4.7)	1.95 (1.50-2.53)	1.02 (0.79-1.33)
Non-Hispanic American Indian/Alaska Native	3020	160 (5.5)	2.29 (1.67-3.14)	1.04 (0.76-1.44)
Non-Hispanic Asian or Pacific Islander	5604	146 (2.4)	1 [Reference]	1 [Reference]
Non-Hispanic Other^c	4170	190 (4.5)	1.86 (1.30-2.65)	1.16 (0.81-1.66)
Age, y
<20	3588	354 (10.4)	2.89 (2.33-3.57)	1.45 (1.15-1.82)
20-24	14 618	909 (6.2)	1.71 (1.46-2.01)	1.11 (0.94-1.32)
25-34	48 883	1826 (3.9)	1.08 (0.94-1.24)	1.00 (0.87-1.14)
≥35	14 961	526 (3.6)	1 [Reference]	1 [Reference]
Hypertension
Yes	8801	515 (6.1)	1.40 (1.21-1.63)	1.22 (1.05-1.42)
No	73 249	3100 (4.3)	1 [Reference]	1 [Reference]
Enrolled in WIC during pregnancy
Yes	29 192	1973 (7.1)	2.20 (1.99-2.43)	1.37 (1.22-1.55)
No	52 858	1642 (3.2)	1 [Reference]	1 [Reference]
Prepregnancy body mass index, kg/m²
Underweight (<18.5)	2893	151 (6.0)	1.69 (1.26-2.26)	1.34 (1.00-1.78)
Normal (18.5-24.9)	37 710	1339 (3.6)	1 [Reference]	1 [Reference]
Overweight (25.0-29.9)	20 850	917 (4.5)	1.27 (1.12-1.45)	1.16 (1.02-1.32)
Obese (≥30.0)	20 597	1208 (6.1)	1.72 (1.52-1.94)	1.36 (1.21-1.54)
Cigarette use during pregnancy
Yes	5635	532 (9.6)	2.30 (1.99-2.66)	1.40 (1.19-1.65)
No	76 415	3083 (4.2)	1 [Reference]	1 [Reference]
Delivery method
Cesarean section	26 545	1337 (5.5)	1.35 (1.22-1.50)	1.32 (1.19-1.47)
Vaginal delivery	55 505	2278 (4.1)	1 [Reference]	1 [Reference]
Infant birthweight, g
<2500	16 399	734 (4.7)	1.05 (0.92-1.19)	0.82 (0.72-0.94)
2500-4000	59 750	2626 (4.5)	1 [Reference]	1 [Reference]
>4000	5901	255 (4.7)	1.07 (0.89-1.28)	1.12 (0.94-1.35)

Abbreviations: GED, General Educational Development; WIC, Special Supplemental Nutrition Program for Women, Infants, and Children.

Data source: Shulman et al.¹⁹

Adjusted for all variables in the table.

Includes women who self-reported ≥1 race or other non-White on the birth certificate.

In both the unadjusted and adjusted models, the prevalence of breastfeeding <1 week postpartum did not differ significantly among women with prepregnancy diabetes and gestational diabetes only compared with those without diabetes. The prevalence of breastfeeding <1 week postpartum among women with prepregnancy diabetes was 5.6%, compared with 4.4% among those without diabetes (aPR = 1.15; 95% CI, 0.91-1.46). The prevalence of breastfeeding <1 week postpartum among women with gestational diabetes was 4.5%, similar to the prevalence among women without diabetes (aPR = 1.01; 95% CI, 0.84-1.20). In sensitivity analyses that included women with missing data on covariates, the results of the adjusted models were consistent with the results reported for the analytic sample (online-only Supplemental Table S2). In additional sensitivity analyses, when comparing breastfeeding cessation at ≤2 weeks and ≤4 weeks, breastfeeding cessation did not differ between women with prepregnancy diabetes and women without diabetes at ≤2 weeks or ≤4 weeks. However, a higher proportion of women with gestational diabetes reported breastfeeding cessation at ≤2 weeks (21.0% vs 19.4%; aPR = 1.09; 95% CI, 1.01-1.18) and ≤4 weeks (33.8% vs 30.3%; aPR = 1.10; 95% CI, 1.04-1.15) compared with women without diabetes.

Discussion

Our study findings from a representative survey of recently postpartum women in 42 sites in the United States during 2016-2018 showed that, among women who initiated breastfeeding, prepregnancy diabetes and gestational diabetes only were not significantly associated with breastfeeding cessation by 1 week postpartum. We adjusted for maternal characteristics, behaviors, and conditions that are thought to act as confounders of diabetes and cessation of breastfeeding.^20-29 Consistent with the literature, these factors were independently associated with breastfeeding <1 week postpartum in our analysis, except for low birth weight, which had an inverse relationship. Specifically, the prevalence of breastfeeding <1 week postpartum was higher among women who were unmarried (vs married), had ≤high school diploma or GED (vs ≥some college), were non-Hispanic Black or non-Hispanic White (vs non-Hispanic Asian or Pacific Islander), were aged <20 years (vs aged ≥35 y), had chronic hypertension (vs not), were enrolled in WIC during pregnancy (vs not), did not have a normal prepregnancy BMI (vs normal prepregnancy BMI), used cigarettes during pregnancy (vs not), and delivered via cesarean section (vs vaginal delivery). These factors could be used to identify women who might need additional support to successfully continue breastfeeding.

Although women might not initiate breastfeeding for a range of reasons (eg, lack of clinician support, household responsibilities, lack of breastfeeding education), the cessation of breastfeeding before women intended to cease breastfeeding could indicate a problem with milk letdown or production.^17,18 Lower levels of serum insulin secretion relative to serum glucose after a glucose challenge and lower serum adiponectin predict delayed lactogenesis.¹¹ These factors, related to metabolic glucose control, suggest that poor glucose control can delay lactogenesis. Studies have demonstrated an association between diabetes and delayed lactogenesis overall or during stage II^12-16 or delayed milk prolactin concentration (a marker for successful lactogenesis stage II).²⁹ However, these studies had small sample sizes, ranging from 39 to 77 women, and, thus, could not control adequately for important factors. A larger analysis (n = 3404) was conducted among a subset of participants in the Black Women’s Health Study, a convenience study of Black women in the United States who were primiparous with a singleton birth during 1995-2009.³⁰ In the Black Women’s Health Study, which controlled for factors including age and BMI, women with any history of prepregnancy diabetes ceased breastfeeding earlier than women without any history of prepregnancy diabetes.

Similarly, gestational diabetes has been linked to delayed lactogenesis. A prospective cohort study of 883 women with gestational diabetes treated with insulin found that 33% of women reported delayed lactogenesis; however, the study did not include a comparison arm of women without gestational diabetes.³¹ Other studies suggesting an association between gestational diabetes and poor lactation were limited by small sample sizes of 16-40 women.^11,32

Our analysis, however, measured breastfeeding cessation by 1 week postpartum for any reason rather than delayed lactogenesis specifically. Furthermore, participants with recognized diabetes who intended to breastfeed might have received targeted interventions to promote their successful breastfeeding, which might have mitigated the effects of their diabetes condition on lactation. Most evidence on the effects of diabetes on lactogenesis, to date, has come from studies with small sample sizes,^11-14,23-29 which may also explain differences. Our analysis was strengthened by the use of data from a large, population-based sample of women from 42 sites. Also, we were able to adjust for many potential confounders of the relationship between diabetes and cessation of breastfeeding at <1 week postpartum, and, in contrast to previous research on this topic,^11-16,30-32 we evaluated prepregnancy diabetes and gestational diabetes separately. This separation is important because the 2 conditions could differ in their effect on lactogenesis. In addition, in sensitivity analyses, gestational diabetes was associated with breastfeeding cessation by 2 weeks and 4 weeks postpartum, which is important given that breastfeeding could reduce diabetes risk; however, whether this finding is related to delayed lactogenesis is unknown.

Limitations

This study had several potential limitations. First, we relied on self-reported data, which are subject to misclassification from social desirability bias and recall bias. Second, data were cross-sectional and can be used only to assess associations. Third, PRAMS did not differentiate between type 1 and type 2 diabetes or the degree to which women were successfully managing their prepregnancy or gestational diabetes. Without an indicator of glycemic control (eg, glycated hemoglobin A_1c) or use of insulin or medications (eg, metformin) for glycemic control, our measure of a true association between diabetes and breastfeeding <1 week postpartum could have been masked. Fourth, we were not able to assess other diabetes-related factors (eg, breastfeeding intention) that might influence a woman’s decision or ability to continue breastfeeding, because such data were not available in PRAMS. Fifth, the wording in the PRAMS survey questions asked women to self-report if they had prepregnancy or gestational diabetes in contrast to asking if they were told by a health care provider that they had these conditions. The broad wording may have led women to overreport diabetes, thus weakening the association between diabetes and breastfeeding <1 week postpartum. Sixth, women excluded from the analysis because of missing data differed from the analytic sample for some characteristics, including marital status, education, race and ethnicity, age, WIC participation, and infant birth weight. While the exclusion of these respondents might have influenced the results, findings for breastfeeding cessation <1 week postpartum in the sensitivity analysis were consistent with findings in the analytic sample. Lastly, the analysis might not have been powered to detect differences by diabetes status given the small proportion of the sample who reported having diabetes.

Conclusion

Regardless of their diabetes status, women who want to breastfeed might benefit from interventions that support their ability to carry out the practice and address differences in breastfeeding <1 week postpartum by demographic factors.³³ Hospital interventions shown to improve breastfeeding outcomes include avoiding use of supplemental feedings and pacifiers, breastfeeding on demand, breastfeeding instruction, having the infant remain with the mother rather than in the hospital nursery, initiating breastfeeding immediately (ideally within 1 hour) after birth, and integrating lactation support and specialists in primary and pediatric care.^33-35 Furthermore, because improving glycemic control among women with insulin-dependent diabetes leads to increased prolactin secretion,¹⁶ future research could assess the role of glycemic control among women with diabetes and breastfeeding cessation.

Supplemental Material

sj-docx-1-phr-10.1177_00333549221099082 – Supplemental material for Prepregnancy and Gestational Diabetes and Cessation of Breastfeeding <1 Week Postpartum, United States, 2016-2018

Supplemental material, sj-docx-1-phr-10.1177_00333549221099082 for Prepregnancy and Gestational Diabetes and Cessation of Breastfeeding <1 Week Postpartum, United States, 2016-2018 by Katherine Kortsmit, Kirsten I. Boone, Lee Warner, Jessica Horan, Julie K. Bower and Maria F. Gallo in Public Health Reports

Footnotes

Disclaimer

The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

ORCID iDs

Katherine Kortsmit, PhD, MPH

Maria F. Gallo, PhD

Supplemental Material

Supplemental material for this article is available online.

References

Grummer-Strawn

Rollins

Summarising the health effects of breastfeeding. Acta Paediatr. 2015;104(467):1-2. doi:10.1111/apa.13136

Chowdhury

Sinha

Sankar

, et al. Breastfeeding and maternal health outcomes: a systematic review and meta-analysis. Acta Paediatr. 2015;104(467):96-113. doi:10.1111/apa.13136

Sankar

Sinha

Chowdhury

, et al. Optimal breastfeeding practices and infant and child mortality: a systematic review and meta-analysis. Acta Paediatr. 2015;104(467):3-13. doi:10.1111/apa.13147

Horta

Loret de

Mola C

Victora

CG.

Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure, and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 2015;104(467):30-37. doi:10.1111/apa.13133

Lodge

Tan

Lau

MXZ

, et al. Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Paediatr. 2015;104(467):38-53. doi:10.1111/apa.13132

Bartick

Schwarz

Green

, et al. Suboptimal breastfeeding in the United States: maternal and pediatric health outcomes and costs. Matern Child Nutr. 2017;13(1):e12366. doi:10.1111/mcn.12366

Section on Breastfeeding; Eidelman

Schanler

Johnston

, et al. Breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827-e841. doi:10.1542/peds.2011-3552

Centers for Disease Control and Prevention. Breastfeeding report card, United States, 2020. Accessed July 5, 2021. https://www.cdc.gov/breastfeeding/data/reportcard.htm

Gunderson

Kim

Quesenberry

, et al. Lactation intensity and fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: the SWIFT cohort. Metabolism. 2014;63(7):941-950. doi:10.1016/j.metabol.2014.04.006

10.

Oza-Frank

Chertok

Bartley

Differences in breast-feeding initiation and continuation by maternal diabetes status. Public Health Nutr. 2015;18(4):727-735. doi:10.1017/S1368980014000792

11.

Nommsen-Rivers

Dolan

Huang

Timing of stage II lactogenesis is predicted by antenatal metabolic health in a cohort of primiparas. Breastfeed Med. 2012;7(1):43-49. doi:10.1089/bfm.2011.0007

12.

Neubauer

Ferris

Chase

, et al. Delayed lactogenesis in women with insulin-dependent diabetes mellitus. Am J Clin Nutr. 1993;58(1):54-60. doi:10.1093/ajcn/58.1.54

13.

De Bortoli

Amir

. Is onset of lactation delayed in women with diabetes in pregnancy? A systematic review. Diabet Med. 2016;33(1):17-24. doi:10.1111/dme.12846

14.

Ferris

Neubauer

Bendel

Green

Ingardia

Reece

EA.

Perinatal lactation protocol and outcome in mothers with and without insulin-dependent diabetes. Am J Clin Nutr. 1993;58(1):43-48. doi:10.1093/ajcn/58.1.43

15.

Murtaugh

Ferris

Capacchione

Reece

EA.

Energy intake and glycemia in lactating women with type 1 diabetes. J Am Diet Assoc. 1998;98(6):642-648. doi:10.1016/S0002-8223(98)00147-3

16.

Ostrom

Ferris

AM.

Prolactin concentration in serum and milk of mothers with and without insulin-dependent diabetes mellitus. Am J Clin Nutr. 1993;58(1):49-53. doi:10.1093/ajcn/58.1.49

17.

Brand

Kothari

Stark

MA.

Factors related to breastfeeding discontinuation between hospital discharge and 2 weeks postpartum. J Perinat Educ. 2011;20(1):36-44. doi:10.1891/1058-1243.20.1.36

18.

Gatti

Maternal perceptions of insufficient milk supply in breastfeeding. J Nurs Scholarsh. 2008;40(4):355-363. doi:10.1111/j.1547-5069.2008.00234.x

19.

Shulman

D’Angelo

Harrison

Smith

Warner

The Pregnancy Risk Assessment Monitoring System (PRAMS): overview of design and methodology. Am J Public Health. 2018;108(10):1305-1313. doi:10.2105/AJPH.2018.304563

20.

Chapman

Pérez-Escamilla

Identification of risk factors for delayed onset of lactation. J Am Diet Assoc. 1999;99(4):450-454. doi:10.1016/S0002-8223(99)00109-1

21.

Pounds

Shostrom

Analyzing factors that impact breastfeeding duration in the postpartum period: a secondary analysis of PRAMS data. Breastfeed Med. 2018;13(5):335-340. doi:10.1089/bfm.2018.0020

22.

Salahudeen

Koshy

Sen

A study of the factors affecting time to onset of lactogenesis-II after parturition. J Pharm Res. 2013;6:68-72. doi:10.1016/j.jopr.2012.11.015

23.

Kong

Nilsson

IAK

Gissler

Lavebratt

Associations of maternal diabetes and body mass index with offspring birth weight and prematurity. JAMA Pediatr. 2019;173(4):371-378. doi:10.1001/jamapediatrics.2018.5541

24.

Moll

Olsson

Landin-Olsson

Women with a predisposition for diabetes have an increased risk of pregnancy complications, especially in combination with pregestational overweight. BMC Pregnancy Childbirth. 2020;20(1):74. doi:10.1186/s12884-020-2741-5

25.

Hosseini

Whitling

Vatanparast

Type 2 diabetes prevalence among Canadian adults—dietary habits and sociodemographic risk factors. Appl Physiol Nutr Metab. 2019;44(1):1099-1104. doi:10.1139/apnm-2018-0567

26.

Kim

J-H

Noh

Choi

J-W

Park

E-C.

Association of education and smoking status on risk of diabetes mellitus: a population-based nationwide cross-sectional study. Int J Environ Res Public Health. 2017;14(6):655. doi:10.3390/ijerph14060655

27.

Rhamezankhani

Azizi

Hadaegh

Association of marital status with diabetes, hypertension, cardiovascular disease and all-cause mortality: a long term follow-up study. PLoS One. 2019;14(4):e0215593. doi:10.1371/journal.pone.0215593

28.

Fletcher

Gulanick

Lamendola

Risk factors for type 2 diabetes mellitus. J Cardiovasc Nurs. 2002;16(2):17-23. doi:10.1097/00005082-200201000-00003

29.

Ding

Tanaka

Zhang

Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185-1200. doi:10.7150/ijms.10001

30.

Chetwynd

Stuebe

Rosenberg

Troester

Palmer

Prepregnancy diabetes and breastfeeding cessation among Black women in the United States. Breastfeed Med. 2019;14(4):249-255. doi:10.1089/bfm.2018.0074

31.

Matias

Dewey

Quesenberry

Jr Gunderson

EP.

Maternal prepregnancy obesity and insulin treatment during pregnancy are independently associated with delayed lactogenesis in women with recent gestational diabetes mellitus. Am J Clin Nutr. 2014;99(1):115-121. doi:10.3945/ajcn.113.073049

32.

Miyake

Tahara

Koike

Tanizawa

Decrease in neonatal suckled milk volume in diabetic women. Eur J Obstet Gynecol Reprod Biol. 1989;33(1):49-53. doi:10.1016/0028-2243(89)90077-4

33.

Fairbank

O’Meara

Renfrew

Woolridge

Sowden

Lister-Sharp

A systematic review to evaluate the effectiveness of interventions to promote the initiation of breastfeeding. Health Technol Assess. 2000;4(25):1-171. doi:10.3310/hta4250

34.

Shealy

Benton-Davis

Grummer-Strawn

LM.

The CDC Guide to Breastfeeding Interventions. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2005.

35.

Feltner

Weber

Stuebe

Grodensky

Orr

Viswanathan

. Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries. No. 18-EHC014-EF. US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2018.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.14 MB